If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, FrancePlatform of Somatic Tumor Molecular Genetics, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, France
Department of Pathology, Université de Tours, Centre Hospitalier Universitaire de Tours, Tours, FranceCARADERM, French Network of Rare Cutaneous Cancer, France
Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive and infiltrative dermohypodermal spindle cell neoplasm, genetically characterised by COL1A1::PDGFB fusion in most cases.
Recently, Chen et al. reported an undescribed TNC::PDGFD fusion transcript in a well-circumscribed and nodular subcutaneous spindle cell neoplasm and discussed the possibility of a DFSP subtype.
Here we report another case of spindle cell neoplasm with TNC::PDGFD and discuss its relationship with the DFSP spectrum.
The local Ethics Committee in Human Research of Tours (France) approved the study (no. ID RCB2009-A01056-51).
A 49-year-old woman presented with a slowly growing infracentimetric tumour at the tip of the nose. A clinical differential was a basal cell carcinoma and surgical resection was performed. Histopathological examination revealed a well-circumscribed mesenchymal neoplasm, measuring 5 mm in diameter and located in the dermis and subcutis without connection to the epidermis (Fig. 1A,B). The neoplasm was composed of small monomorphous spindle-shaped cells with regular small folded or indented nuclei and a moderate amount of eosinophilic cytoplasm (Fig. 1C). Pleomorphism, mitotic activity, and necrosis were not seen. These cellular fields were centred by large hyaline lobulated areas composed of dense collagen bundles with scattered small nuclei and inconspicuous cytoplasms (Fig. 1D). These features were reminiscent of immature cartilage while no lamellar bone or fibrillar ossification was seen.
Fig. 1(A) The lesion consists of a well-circumscribed and poly-lobed dermal mass; (B) any connection to the epidermis is observed; (C) neoplastic spindle cells have oval, folded or indented nuclei and palely eosinophilic cytoplasm; (D) tumours cells are arranged around dense hyalin collagen (H&E stain).
Immunohistochemical investigation of the case showed negativity for CD34 (Fig. 2A), CKAE1/AE3, EMA, BerEP4, p63, SOX10, PS100, Melan-A, GFAP, SMA, Desmin, CD31, neuron-specific enolase (NSE), neurofilament (NF), MUC4, pan-TRK, ALK5A4 and β-catenin (Fig. 2B). Therefore, RNA sequencing was performed on formalin-fixed, paraffin-embedded (FFPE) tissue using the Archer FusionPlex Sarcoma Panel (ArcherDX, USA) on a MiSeq (300 cycles; Illumina USA). Sequencing data were analysed via the Archer automated analysis pipeline, which revealed a TNC::PDGFD fusion transcript.
Fig. 2(A) Tumour cells are negative for CD34 (endothelial cells positive control). (B) No nuclear expression of β-catenin is observed.
Platelet Derived Growth Factor D (PDGFD) is located on chromosome 11q22.3 and encodes a platelet-derived growth factor family protein. Binding and activation of its homologous receptor PDGFR-β can regulate cell proliferation, migration, invasion, and angiogenesis by the crosstalk of many signalling pathways.
Recently, fusions involving PDGFD have been reported in DFSP cases lacking COL1A1::PDGFB fusion. In these cases, a fusion was observed between PDGFD and COL6A3 or EMILIN2 in 40% of the cases. Similarly to COL1A1::PDGFB fusions, PDGFD rearrangements can result in autocrine activation by signalling of the PDGFR-β receptor tyrosine kinase.
Molecular characterization of dermatofibrosarcoma protuberans: the clinicopathologic significance of uncommon fusion gene rearrangements and their diagnostic importance in the exclusively subcutaneous and circumscribed lesions.
Tenascin-C (TNC) is located on chromosome 9q33.1 and is a member of the tenascin gene family which encodes extracellular matrix proteins with a wide range of different functions with a spatially and temporally restricted tissue distribution.
Its expression is induced by stress or mechanical and chemical injury and has oncogenic properties through the promotion of cell proliferation, migration and angiogenesis, which has been described as an important factor of metastatic spread by providing protection against apoptosis.
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.
Recently, Chen et al. reported a subcutaneous spindle cell tumour with TNC::PDGFD fusion and proposed that it could represent a subtype of fibrosarcomatous DFSP.
However, in our observation, the well-delimitated nodular silhouette, the lack of infiltration, the hyaline hypocellular areas and the negativity of CD34 were not in keeping with the diagnosis of DFSP. Therefore, although confirmation of more cases is required for further characterisation, the morphological and immunohistochemical characteristics observed in these two cases suggest that superficial TNC::PDGFD-rearranged spindle cell tumours may constitute a distinct entity.
Conflicts of interest and sources of funding
The authors state that there are no conflicts of interest to disclose.
References
Mentzel T.
Pedeutour F.
Dermatofibrosarcoma protuberans. In: WHO Classification of Tumours Editorial Board.
5th edition. WHO Classification of Tumours: Soft Tissue and Bone Tumours. IARC Press,
Lyon2020 (100–3)
Molecular characterization of dermatofibrosarcoma protuberans: the clinicopathologic significance of uncommon fusion gene rearrangements and their diagnostic importance in the exclusively subcutaneous and circumscribed lesions.
Identification of tumors with NRG1 rearrangement, including a novel putative pathogenic UNC5D-NRG1 gene fusion in prostate cancer by data-drilling a de-identified tumor database.